Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INIPARIB for Metastases to bone: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 13 adverse event reports in the FDA FAERS database where INIPARIB was used for Metastases to bone.

Most Reported Side Effects for INIPARIB

Side Effect Reports % Deaths Hosp.
Anaemia 16 44.4% 0 16
Thrombocytopenia 16 44.4% 0 16
Malignant neoplasm progression 15 41.7% 0 15
Disease progression 10 27.8% 0 10
Invasive ductal breast carcinoma 10 27.8% 0 10
Metastases to bone marrow 10 27.8% 0 10
Product use in unapproved indication 10 27.8% 0 10
Bone marrow infiltration 6 16.7% 0 6

Other Indications for INIPARIB

Invasive ductal breast carcinoma (15) Breast cancer (8)

Other Drugs Used for Metastases to bone

DENOSUMAB (5,083) ZOLEDRONIC ACID (3,177) RADIUM RA-223 DICHLORIDE (1,501) PALBOCICLIB (556) CABOZANTINIB S-MALATE (514) ENZALUTAMIDE (439) XGEVA (412) RIBOCICLIB (383) LETROZOLE (263) CARBOPLATIN (254)

Related Pages

INIPARIB Full Profile All Metastases to bone Drugs INIPARIB Demographics INIPARIB Timeline